Use of levetiracetam in pediatric refractory status epilepticus

Authors

  • Kashyap Narsingh Shakya Professor; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
  • Anwesh Bhatta Lecturer; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
  • Samjhana Phuyal Second year Resident; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
  • Arbind Yadav First year Resident, Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.

DOI:

https://doi.org/10.3126/jkmc.v8i1.25268

Keywords:

Levetiracetam, Antiepileptic drug, Pediatric refractory seizure

Abstract

Refractory status epilepticus, with persistence of seizures despite initial intravenous benzodiazepine and one secondline intravenous antiepileptic drug occurs in nine percent to 44% of the patients with status epilepticus. Aggressive treatment is needed to control such seizures with drug refractoriness. A case of a 2-year-old boy treated with intravenous levetiracetam with cessation of seizures, averting the need for general anesthesia is reported. Option of using levetiracetam in refractory status epilepticus is suggested.

Downloads

Download data is not yet available.
Abstract
380
pdf
342

Downloads

Published

2019-08-18

How to Cite

Shakya, K. N., Bhatta, A., Phuyal, S., & Yadav, A. (2019). Use of levetiracetam in pediatric refractory status epilepticus. Journal of Kathmandu Medical College, 8(1), 41–43. https://doi.org/10.3126/jkmc.v8i1.25268

Issue

Section

Case Reports

Most read articles by the same author(s)